Literature DB >> 18046264

Providers' perceived barriers to sexually transmitted disease care in 2 large health maintenance organizations.

Hayley Mark1, Kathleen Irwin, Maya Sternberg, Lynda Anderson, David Magid, Michael Stiffman.   

Abstract

GOAL: To identify providers' perceived barriers to sexually transmitted disease (STD) care in 2 health plans and plan-, clinician-, and patient-level factors that were associated with these barriers in order to inform quality improvement interventions. STUDY
DESIGN: Surveys were mailed to a stratified sample of 1000 physicians, physician assistants, and nurse practitioners at 2 large health plans in 1999-2000. Of the 743 (82%) providers who received questionnaires and responded, data were analyzed from 699 with complete specialty information.
RESULTS: Ninety-five percent of providers identified at least 1 barrier to STD care. The most commonly cited barriers in both plans related to insufficient time and staff to address STDs, to counsel patients or manage sex partners, to keep current with managing high-risk patients, and to monitor patient adherence to recommendations to abstain from sex or use condoms during treatment. Nurse practitioners and specialists in obstetrics and gynecology were more likely to cite these barriers. Providers in staff models were more likely to cite the most common patient-level barriers. Few cited barriers related to diagnostic and treatment services.
CONCLUSIONS: Interventions in health plans are necessary to address constraints related to time and staff performing STD related care, keeping current with managing high-risk patients, and supporting patient adherence to provider recommendations.

Entities:  

Mesh:

Year:  2008        PMID: 18046264     DOI: 10.1097/OLQ.0b013e31815a9f7e

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

1.  Budgetary Impact of Compliance With STI Screening Guidelines in Persons Living With HIV.

Authors:  Ellen F Eaton; Kathryn Hudak; Christina A Muzny
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

2.  Systems Approaches to Improving Rates of Extragenital Chlamydia and Gonorrhea Screening Among Men Who Have Sex With Men Engaged in Human Immunodeficiency Virus Care.

Authors:  Kyle T Bernstein
Journal:  Sex Transm Dis       Date:  2015-10       Impact factor: 2.830

3.  Disparities in safe sex counseling & behavior among individuals with substance dependence: a cross-sectional study.

Authors:  Meredith M D'Amore; Debbie M Cheng; Donald Allensworth-Davies; Jeffrey H Samet; Richard Saitz
Journal:  Reprod Health       Date:  2012-12-31       Impact factor: 3.223

4.  Human Immunodeficiency Virus Diagnosis After a Syphilis, Gonorrhea, or Repeat Diagnosis Among Males Including non-Men Who Have Sex With Men: What Is the Incidence?

Authors:  Carla Tilchin; Christina M Schumacher; Kevin J Psoter; Elizabeth Humes; Ravikiran Muvva; Patrick Chaulk; William Checkley; Jacky M Jennings
Journal:  Sex Transm Dis       Date:  2019-04       Impact factor: 2.830

5.  Direct-to-Consumer Sexually Transmitted Infection Testing Services: A Position Statement from the American Sexually Transmitted Diseases Association.

Authors:  Cara Exten; Casey N Pinto; Anne M Gaynor; Beth Meyerson; Stacey B Griner; Barbara Van Der Pol
Journal:  Sex Transm Dis       Date:  2021-11-01       Impact factor: 3.868

6.  Sexually transmitted infection laboratory testing and education trends in US outpatient physician offices, 2009-2016.

Authors:  Amina R Zeidan; Kelsey Strey; Michelle N Vargas; Kelly R Reveles
Journal:  Fam Med Community Health       Date:  2021-06

7.  'Repeat testing without having 'the talk' is not meaningful'-healthcare providers' perceptions on finding a balance between Chlamydia trachomatis testing and primary prevention strategies. A qualitative study in Stockholm, Sweden.

Authors:  Anna Nielsen; Ayesha de Costa; Kristina Gemzell-Danielsson; Jens Boman; M Salazar
Journal:  BMJ Open       Date:  2020-08-05       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.